Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · IEX Real-Time Price · USD

44.42

-0.75 (-1.66%)

At close: Apr 25, 2024, 4:00 PM

44.68

+0.26 (0.59%)

After-hours: Apr 25, 2024, 6:33 PM EDT

Legend Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	1,308	840.05	852.46	505.69	158.92	210.17
Short-Term Investments	1.02	186.87	31.38	0.38	0.26	6.27
Cash & Cash Equivalents	1,309	1,027	883.84	506.07	159.18	216.44
Cash Growth	27.48%	16.19%	74.65%	217.93%	-26.45%	-
Receivables	100.04	0.09	50.41	74.98	29.99	26.22
Inventory	19.43	10.35	1.75	1.8	1.16	1.14
Other Current Assets	69.25	61.76	13.85	10.01	16.78	83.17
Total Current Assets	1,498	1,099	949.85	592.86	207.1	326.96
Property, Plant & Equipment	189.23	160.76	140.79	121.1	79.43	31.89
Long-Term Investments	4.36	0	4.71	0	0	0
Goodwill and Intangibles	4.06	3.41	4.68	2.85	0.52	0.05
Other Long-Term Assets	153.16	67.68	19.44	4.2	0.67	70.15
Total Long-Term Assets	350.81	231.84	169.62	128.15	80.61	102.09
Total Assets	1,849	1,331	1,119	721.01	287.72	429.05
Accounts Payable	152.96	217	130.6	104.41	80.44	43.95
Deferred Revenue	100.97	0	0	330.09	324.06	297.59
Current Debt	3.18	3.56	0.91	1.46	1.03	0.37
Other Current Liabilities	-40.69	77.22	97.69	-274.79	-277.77	-182.73
Total Current Liabilities	216.42	297.79	229.2	161.17	127.76	159.19
Long-Term Debt	325.5	280.97	122.06	1.91	5.06	3.94
Other Long-Term Liabilities	55.32	7.89	2.26	277.68	277.77	257.27
Total Long-Term Liabilities	380.82	288.86	124.32	279.59	282.82	261.21
Total Liabilities	597.24	586.65	353.52	440.75	410.58	420.4
Total Debt	328.67	284.53	122.97	3.37	6.09	4.32
Debt Growth	15.51%	131.39%	3545.60%	-44.57%	40.95%	-
Shareholders' Equity	1,251	744.31	765.94	280.26	-122.87	8.65
Net Cash / Debt	980.4	742.39	760.87	502.7	153.09	212.12
Net Cash / Debt Growth	32.06%	-2.43%	51.36%	228.36%	-27.83%	-
Net Cash Per Share	2.78	2.33	2.70	2.13	0.77	-
Working Capital	1,281	801.33	720.65	431.69	79.34	167.77
Book Value Per Share	7.11	4.68	5.44	2.37	-1.23	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).